Unveiling myocardial microstructure shifts: exploring the impact of diabetes in stable CAD patients through CMR T1 mapping

[1]  S. Plein,et al.  The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: a prospective cross-sectional cohort study , 2023, Cardiovascular Diabetology.

[2]  S. Blankenberg,et al.  Cardiac magnetic resonance feature tracking global and segmental strain in acute and chronic ST-elevation myocardial infarction , 2022, Scientific Reports.

[3]  Yue Gao,et al.  Cardiac magnetic resonance T1 mapping for evaluating myocardial fibrosis in patients with type 2 diabetes mellitus: correlation with left ventricular longitudinal diastolic dysfunction , 2022, European Radiology.

[4]  Lawrence A Leiter,et al.  Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease. , 2021, JACC. Cardiovascular imaging.

[5]  F. von Knobelsdorff-Brenkenhoff,et al.  Quantification of myocardial strain assessed by cardiovascular magnetic resonance feature tracking in healthy subjects—influence of segmentation and analysis software , 2020, European Radiology.

[6]  E. Nagel,et al.  Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.

[7]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.

[8]  Amit R. Patel,et al.  Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease. , 2020, Magnetic resonance imaging.

[9]  Amit R. Patel,et al.  Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement , 2019, Journal of Cardiovascular Magnetic Resonance.

[10]  W. Rathmann,et al.  Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population , 2018, European heart journal cardiovascular Imaging.

[11]  A. Greiser,et al.  Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain , 2018, Cardiovascular Diabetology.

[12]  K. Diao,et al.  Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis , 2016, Journal of Cardiovascular Magnetic Resonance.

[13]  S. Plein,et al.  Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.

[14]  G. Pedrizzetti,et al.  Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use , 2016, Journal of Cardiovascular Magnetic Resonance.

[15]  B. Gersh,et al.  Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial. , 2016, The Annals of thoracic surgery.

[16]  Daniel Messroghli,et al.  State of the Art: Clinical Applications of Cardiac T1 Mapping. , 2016, Radiology.

[17]  Piet Claus,et al.  Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles, Normal Values, and Clinical Applications. , 2015, JACC. Cardiovascular imaging.

[18]  William T. Clarke,et al.  Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes , 2015, Diabetes.

[19]  B. Gerber,et al.  Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T , 2015, Journal of Cardiovascular Magnetic Resonance.

[20]  A. Voss,et al.  Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. , 2015, European heart journal cardiovascular Imaging.

[21]  Angelo Avogaro,et al.  Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. , 2015, JACC. Heart failure.

[22]  A. Satoskar,et al.  Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria , 2013, Molecular and Cellular Biochemistry.

[23]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[24]  James O. Mudd,et al.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.

[25]  P. Kellman,et al.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.

[26]  Jeroen J. Bax,et al.  Association Between Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping and Subclinical Myocardial Dysfunction in Diabetic Patients: A Pilot Study , 2012, Circulation. Cardiovascular imaging.

[27]  P. Croisille,et al.  Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[29]  Jeroen J. Bax,et al.  Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. , 2009, The American journal of cardiology.

[30]  S. Bansilal,et al.  Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. , 2008, The American journal of medicine.

[31]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[32]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.